We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $798M
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+20.93%
3 Year Est. Return
+63.23%
5 Year Est. Return
+80.45%
10 Year Est. Return
+239.89%
AUM
$348M
AUM Growth
+$51.1M
Cap. Flow
+$11.6M
Cap. Flow %
3.35%
Top 10 Hldgs %
32.79%
Holding
156
New
12
Increased
53
Reduced
49
Closed
4

Sector Composition

1 Healthcare 17.86%
2 Technology 13.26%
3 Consumer Staples 11.19%
4 Financials 10.19%
5 Communication Services 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$18.9M 5.45%
142,759
-1,208
-0.8% -$145K
SCHX icon
2
Schwab US Large- Cap ETF
SCHX
$71.7B
$16.4M 4.71%
1,079,502
+26,028
+2% +$372K
SCHF icon
3
Schwab International Equity ETF
SCHF
$65.4B
$12.8M 3.68%
710,788
+28,552
+4% +$481K
TMO icon
4
Thermo Fisher Scientific
TMO
$198B
$11.1M 3.19%
23,843
+1,810
+8% +$849K
VBR icon
5
Vanguard Small-Cap Value ETF
VBR
$37.1B
$10.7M 3.08%
75,417
+4,231
+6% +$546K
RSP icon
6
Invesco S&P 500 Equal Weight ETF
RSP
$96.4B
$10.6M 3.05%
83,154
-601
-0.7% -$71.5K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.23T
$9.01M 2.59%
102,840
+120
+0.1% +$10.1K
DHR icon
8
Danaher
DHR
$144B
$8.92M 2.57%
45,291
+688
+2% +$138K
PG icon
9
Procter & Gamble
PG
$349B
$8.01M 2.3%
57,586
+496
+0.9% +$69.3K
VIG icon
10
Vanguard Dividend Appreciation ETF
VIG
$111B
$7.53M 2.17%
53,351
-34
-0.1% -$4.61K
BDX icon
11
Becton Dickinson
BDX
$43.6B
$7.42M 2.13%
30,380
+546
+2% +$127K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.06T
$6.67M 1.92%
28,766
+739
+3% +$163K
SCHE icon
13
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$6.63M 1.91%
216,183
+18,854
+10% +$547K
SBUX icon
14
Starbucks
SBUX
$120B
$6.43M 1.85%
60,074
-899
-1% -$85.8K
MSFT icon
15
Microsoft
MSFT
$2.93T
$6.11M 1.76%
27,467
+5,332
+24% +$1.15M
NKE icon
16
Nike
NKE
$64.9B
$5.97M 1.72%
42,223
-90
-0.2% -$11.9K
UL icon
17
Unilever
UL
$134B
$5.62M 1.62%
82,768
+1,812
+2% +$123K
JNJ icon
18
Johnson & Johnson
JNJ
$609B
$5.46M 1.57%
34,709
+602
+2% +$88.8K
EEFT icon
19
Euronet Worldwide
EEFT
$3.1B
$5.23M 1.5%
36,083
+1,160
+3% +$135K
DIS icon
20
Walt Disney
DIS
$170B
$5.14M 1.48%
28,350
+44
+0.2% +$6.32K
DEO icon
21
Diageo
DEO
$46.7B
$5.06M 1.46%
31,879
+477
+2% +$71.1K
VZ icon
22
Verizon
VZ
$182B
$4.53M 1.3%
77,175
+400
+0.5% +$23.8K
NVDA icon
23
NVIDIA
NVDA
$4.91T
$4.5M 1.29%
344,640
-1,080
-0.3% -$14.5K
STE icon
24
Steris
STE
$21.2B
$4.35M 1.25%
22,963
+825
+4% +$154K
SCHA icon
25
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$4.16M 1.2%
186,972
+8,048
+4% +$160K

Similar funds

Kavar Capital Partners Group's Q4 2020 Portfolio in Review

As of Q4 2020, Kavar Capital Partners Group held 156 positions worth $348M, up 17% from $297M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kavar Capital Partners Group deployed $11.6M of net new capital in Q4 2020, opening 12 new positions and adding to 53 existing holdings. Its largest new stake was Vanguard Value ETF: 14,484 shares worth $1.72M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Griffon, an estimated $258K trimmed.

  • Kavar Capital Partners Group's largest Q4 2020 buy was Vanguard Value ETF: 14,484 shares worth $1.72M.
  • Kavar Capital Partners Group added most to Edwards Lifesciences in Q4 2020, an estimated $1.32M increase.
  • Kavar Capital Partners Group's biggest Q4 2020 reduction was Griffon, cutting an estimated $258K.
  • Kavar Capital Partners Group fully exited Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2020, selling an estimated $459K.
  • Kavar Capital Partners Group's ten largest holdings make up 33% of its $348M portfolio in Q4 2020.
  • Kavar Capital Partners Group opened 12 new positions and closed 4 in Q4 2020.
  • Kavar Capital Partners Group's portfolio value rose 17% quarter-over-quarter to $348M.

Based on Kavar Capital Partners Group's 13F filing for Q4 2020, filed 5 Feb 2021.